Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial
File(s)
Author(s)
Sclafani, F
Chau, I
Cunningham, D
Peckitt, C
Lampis, A
Type
Journal Article
Date Issued
2015-07-10
Date Acceptance
2015-06-26
Citation
Annals of Oncology, 2015, 26 (9), pp.1936-1941
URI
DOI
ISSN
1569-8041
Publisher
Oxford University Press (OUP)
Start Page
1936
End Page
1941
Journal / Book Title
Annals of Oncology
Volume
26
Issue
9
Copyright Statement
© The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited
License URL
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
LCS-6 KRAS variant
single-nucleotide polymorphism
let-7
KRAS
cetuximab
rectal cancer
BINDING SITE POLYMORPHISM
LET-7 MICRORNA-BINDING
COLORECTAL-CANCER
3'-UNTRANSLATED REGION
CLINICAL-TRIAL
COLON-CANCER
CETUXIMAB
RAS
5-FLUOROURACIL
OXALIPLATIN
Oncology & Carcinogenesis
1112 Oncology And Carcinogenesis
Publication Status
Published